David Aitken Email & Phone Number

United Kingdom

Cardiff, Wales, United Kingdom

• Associate Consultant in the Value & Access team.
• Project management across a range of functions and clients
• Development and strategic review of submissions to UK HTA bodies
• Engagement with clinical/economic experts through advisory boards and structured interviews to optimise product launch strategy
• Conceptualisation of system frameworks to demonstrate multi-stakeholder value perspectives
• Proposal development

Cardiff, Wales, United Kingdom

• Health Technology Assessment (HTA):
• Supported the development of value propositions and materials for HTA submissions that fully demonstrated the unmet medical need and reflected the value of treatment
• Assisted management of HTA projectsHealth Economics:
• Developed critical appraisal skills for economic evaluations, health economic models, and health economic analyses
• Supported the development of health economic models for a variety of structures, approaches and disease areasValue Communications and Medical Writing:
• Contributed to the writing and strategic development of conference materials and manuscripts, including pre- and post-submission support

Oxford, England, United Kingdom

Investigated the effect of the R132H mutation in isocitrate dehydrogenase 1 (IDH1) on metabolism, the chromatin landscape, 3D chromatin architecture and gene expression in a glioblastoma cell line. Used a combination of predictive biomarker assays (EpiSwitch Explorer Arrays) and novel sequencing techniques (Single-Nucleotide Resolution 4sU-Sequencing).

Cardiff, United Kingdom

Investigated the kinetics and combustion of butanol isomers using ab initio and semi-empirical computational methods. Modelled the Waddington mechanism of butanol combustion using density functional theory (B3LYP) and coupled cluster theory (CCSD[T]) methods with various basis sets. Calculated and analysed restricted Hartree-Fock & Kohn-Sham energies..